Our research program can be divided programmatically into three focus areas in the field of comparative orthopedics and regenerative medicine: study of pathological responses in osteoarthritis, elucidation of the role of the gut microbiome in orthopedic conditions, and the development of cellular and immunomodulatory approaches to treat musculoskeletal disease. Our laboratory’s work spans bench to bedside, integrating basic molecular-cellular biology techniques and preclinical animal models of orthopedic conditions to inform clinical interventions in veterinary and human patients. The overall goal is to pursue a basic study of musculoskeletal homeostasis and disease to develop therapeutic strategies addressing key orthopedic challenges including osteoarthritis and multidrug-resistant infection.
The Pezzanite research lab is part of the:
Collaborations
research project
Transcriptomic response in post-traumatic osteoarthritis
This study will highlight the role that cells of the immune system play to contribute to disease progression of osteoarthritis toward the goal of developing treatments for each stage of disease.
research project
Role of the gut microbiome and bacterial metabolites in osteoarthritis
These studies will further our understanding of the mechanistic underpinnings of microbiome-skeletal interactions in disease progression.
research project
Identification of optimal senolytic drug therapies to treat osteoarthritis
These studies will investigate and compare biological activity of senolytic drugs to selectively induce apoptosis and modulate senescence associated secretory phenotype for improved osteoarthritis treatment.
research project
Translational musculoskeletal research
These studies seek to promote limb restoration and functional mobility, with translational application to both veterinary and human patients.
Publications
Characterization of the single cell landscape in normal and osteoarthritic equine joints.
Ammons DT, Chow L, Goodrich L, et al. Ann Transl Med. 2024;12(5):88. doi:10.21037/atm-24-40
Targeted transcriptomic analysis of synovial tissues from horses with septic arthritis treated with immune-activated mesenchymal stromal cells reveals induction of T-cell response pathways.
Pezzanite LM, Chow L, Engiles JB, et al. J Am Vet Med Assoc. 2024;262(S1):S73-S82. Published 2024 Feb 3. doi:10.2460/javma.23.10.0561
Erythrocyte removal from bone marrow aspirate concentrate improves efficacy as intra-articular cellular therapy in a rodent osteoarthritis model.
Pezzanite LM, Timkovich AE, Sikes KJ, et al. Ann Transl Med. 2023;11(9):311. doi:10.21037/atm-22-4256
Distinct differences in immunological properties of equine orthobiologics revealed by functional and transcriptomic analysis using an activated macrophage readout system.
Pezzanite LM, Chow L, Griffenhagen GM, et al. Front Vet Sci. 2023;10:1109473. Published 2023 Feb 16. doi:10.3389/fvets.2023.1109473
Regenerative therapies in equine practice: Top 10 EVJ papers 2019-2024.
Pezzanite L. Clinical insights: Equine Vet J. 2024;56(5):824-831. doi:10.1111/evj.14136
more publications
People
Jacob Singer
Ph.D. Graduate Research Assistant
CSU Translational Medicine Institute hosts University of Colorado Bone-Anchored Limb Research Group for collaborative research discussions.
Ph.D. student Jacob Singer presents his poster as a visiting trainee poster finalist at the University of Colorado Annual Orthopedic Research Symposium and D’Ambrosia Diversity Lectureship.
Pezzanite lab team at the University of Colorado Annual Orthopedic Research Symposium and D’Ambrosia Diversity Lectureship.
CSU Investigators Laurie Goodrich, Steven Dow, Lynn Pezzanite partner with orthopedic trauma surgeon Jason Stoneback of University of Colorado on studies investigating the role of the immune system in post-traumatic osteoarthritis progression.
contact information
Offices:
TMI 236
Laboratories:
Translational Medicine Institute
Office: (970) 297-4296
[email protected]